Ebrantil and blood lactate dehydrogenase increased Patient Reports February 10, 2012

Ebrantil Side Effects Report #5743559-4
Ebrantil side effect was reported by a Physician from JAPAN on May 14, 2008. Male patient, 79 years of age, weighting 143.3 lb, was diagnosed with benign prostatic hyperplasia, cerebral infarction, hypertension, dizziness  and was treated with Ebrantil. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood amylase increased, blood cholinesterase decreased, blood glucose increased, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, blood uric acid decreased, c-reactive protein increased. Ebrantil dosage: 30 MG, UNK. During the same period patient was treated with KETAS, ENDOXAN, ELASPOL, PLAVIX, DIOVAN, MERISLON, URIEF. Patient was hospitalized. Patient recovered.